Borrelia Infections: Clinical Trials

5 trials for Borrelia Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 3, Not yet recruiting 1, Recruiting 1

Follow Borrelia Infections: new trials by email Literature Review of Borrelia Infections trials Research Report on Borrelia Infections

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.
Hydroxychloroquin, Placebo, Doxycycline - Lyme Borreliosis, Nervous System
Phase 4Not yet recruitingRadboud University Medical Center502027-03-012026-08-27
Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))
Amoxicillin + Saccharomyces boulardii CNCM I-745, Amoxicillin + Placebo, Stool samples - Erythema Migrans of Lyme Disease
Phase 4RecruitingBiocodex1202025-07-162025-08-27
Study of Lyme Neuroborreliosis
Doxycycline, Ceftriaxone - Lyme Neuroborreliosis
Phase 4CompletedTurku University Hospital2102012-08-012019-05-13
Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice
Doxycycline, Phenoxymethylpenicillin, Amoxicillin - Erythema Migrans, Erythema Chronicum Migrans
Phase 4CompletedMorten Lindbaek2252011-06-012014-12-12
Persistent Lyme Empiric Antibiotic Study Europe
Doxycycline, Clarithromycin and hydroxychloroquine, Placebo - Lyme Disease, Borrelia Infection
Phase 4CompletedRadboud University Medical Center2802010-09-012016-09-08

Narrower conditions

Lyme Disease (3)  ·  Erythema Chronicum Migrans (2)  ·  Glossitis, Benign Migratory (2)  ·  Lyme Neuroborreliosis (2)

Broader conditions

Bacterial Infections (5)  ·  Bacterial Infections and Mycoses (5)  ·  Gram-Negative Bacterial Infections (5)  ·  Infections (5)  ·  Spirochaetales Infections (5)  ·  Tick-Borne Diseases (5)  ·  Vector Borne Diseases (5)  ·  Central Nervous System Bacterial Infections (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Infections (2)  ·  Erythema (2)  ·  Glossitis (2)  ·  Lyme Disease (2)  ·  Mouth Diseases (2)

Interventions

Doxycycline (4)  ·  Amoxicillin (2)  ·  Hydroxychloroquine (2)  ·  Ceftriaxone (1)  ·  Clarithromycin (1)  ·  Penicillin V (1)

Sponsors

Radboud University Medical Center (2)  ·  Biocodex (1)  ·  Morten Lindbaek (1)  ·  Turku University Hospital (1)

Countries

Finland (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Slovenia (1)

Top investigators

Bart-Jan Kullberg, Prof., M.D. (1)  ·  Elisa Kortela (1)  ·  Hadewych Ter Hofstede, Dr. (1)  ·  Laura Airas (1)  ·  Mari Kanerva (1)  ·  Morten Lindbak, Professor (1)

Results publications

PMID 27028911, PMID 29505880, PMID 30796143, PMID 31590634, PMID 32133487, PMID 34031759

NIH funding

2009 (1), 2023 (1), 2025 (1)